Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Marketing activities today generate unprecedented amounts of data.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity 98

Diversity Innovation Biotechnology Short-term 98

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). poor management of relations with Chinese regulators and the government.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. That is good news for managers and investors. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

OCTOBER 6, 2016

Organizations are continuously promoting people into management, and those new leaders struggle with the transition. So they’re looking for ways to cultivate those competencies and, in the process, feeding the fad-driven leadership development market. How talent management is changing. Insight Center.

Leadership Pipeline 12

Leadership Pipeline Leadership After Action Review Pharmaceuticals 12

Harvard Business Review

AUGUST 8, 2018

Through his academic research and teaching at HBS, Jensen promulgated a new financial orthodoxy that corporate managers should avoid diversification and instead focus on the firm’s core competencies. ” The thinking on diversification later changed, turning into skepticism in the 1970s and outright criticism in the 1980s.

Influence 12

Influence Education Pharmaceuticals Finance 12

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 24, 2017

After all, there’s a subtle difference in how these two disciplines train people to understand and manage risks: Legal training focuses on the downside of particular actions, while business training may emphasize the upsides for shareholder value from risk taking. First, we looked at the matching between firm types and CEOs.

CEO 8

CEO Accrual Accounting Pharmaceuticals Banking 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. In cases like this, it may be instructive to think about the circumstances through the lens of a portfolio manager who is choosing how to allocate investments.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MAY 7, 2015

On the other hand, most large sample studies in the accounting literature show something different: firms that manage their earnings perform better than firms that don’t (and not just in the short term). HBR: What got you interested in what impact short-term earnings management has on long-term performance? Insight Center.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. The bulk of HCIT investment supports startups that sell data — clinical or operational information that is otherwise difficult for clients to obtain or to organize. demographics.

Health Care 9

Health Care Levitt Competitive Advantage Pharmaceuticals 9

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Risk and outcomes, as the scenario plays out, will be managed by predictive models, which are powered by machine learning algorithms that will improve their accuracy rates over time.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. Part of the problem may be in the backgrounds that companies desired: 85% of COOs had experience in operations, strategy, or finance. What role does he or she play in the organization? What do you think?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Talent Management. ” Other talent management concerns that were mentioned once include: motivating people through hard times, retention and development, and managing diversity and cultural differences. .”

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 5, 2018

For example, in 2009 professors Brian Becker, Mark Huselid, and Richard Beatty estimated that in most companies less than 15% of jobs are what they call strategic positions and said management should focus “disproportionate investments” on finding A players for those jobs. Connectors in the middle. High-potential future leaders.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

OCTOBER 26, 2017

But don’t assume your impressive résumé will guarantee you an offer, says Berrin Erdogan, a professor of management at Portland State University and the lead author of a recent study on the subject. “Hiring managers are not always eager to bring on someone who is overqualified.”

How To 12

How To Long-term Marketing Case Study 12

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

JANUARY 13, 2015

Nearly all competitive markets confront firms with this choice. In pharmaceuticals, there are blockbuster drugs targeted at mass-markets segments. Cost reductions versus lowest costs: lowering cost doesn’t necessarily mean your cost is lower than competitors and, in any market, there is only one lowest cost competitor.

Market Segmentation 8

Market Segmentation Mass Marketing Price Pharmaceuticals 8

Harvard Business Review

JULY 7, 2011

The question on the tip of everyone's tongue when this type of nightmare takes hold is, "Why doesn't senior management do something?" The less obvious, but equally culpable, individual is often the manager who fumbles the job of taking this employee to task promptly. I'm at a loss when it comes to managing Cynthia," Roger confessed.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

SEPTEMBER 29, 2011

They can signal to the market the types of investors they wish to own their shares. The board of directors and top management should spend the largest chunk of their time communicating with long-term investors. Globally, these asset owners manage significant sums, exceeding $50 trillion at the end of 2009.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. (To do this, we take the firm’s returns, deduct the cost of capital, and multiply by the firm’s total invested capital.)

Industry 12

Industry Company GDP Bottom-up 12

In the CEO Afterlife

JUNE 19, 2011

A Boomer’s Advice to Marketers: Go Ahead, Make My Day. by John • June 19, 2011 • Life , Marketing , Strategy • 1 Comment. Today, we represent a marvelous marketing opportunity. We operate by the mantra of “use it or you lose it.” Aha,” say the savvy marketers. In the CEO Afterlife. Leadership.

Advice 147

Advice Marketing Marketing Strategy Brand 147

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

MAY 16, 2011

But most true collaborations cannot be controlled with fixed terms that are defined in advance — they must be managed through relational contracts that allow you to respond flexibly to new information. Their challenge then is to learn how to manage these partnerships differently than the vendor relationships they had before.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

NOVEMBER 24, 2015

Joint value in combinations typically comes from one of four sources: increased scale, expanded scope, improvements in management coordination, and expansion of future options. The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

MARCH 27, 2018

“It’s no good fighting an election campaign on the facts,” Cambridge Analytica’s managing director told an undercover reporter, “because actually it’s all about emotion.” The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power.

Company 10

Company Advertising Incentives Engineering 10